Stock Overview
Cytokinetics Inc (CYTK)
NASDAQ · Healthcare · Biotechnology
Cytokinetics Inc is a Healthcare company with a market capitalization of $11.16B.
Market Cap
$11.16B
Forward P/E
117.7
Price/Sales
105.5
Price/Book
60.3
EV/EBITDA
-15.8
Beta
0.44
EPS (TTM)
$-6.85
Profit Margin
0.0%
ROE
-572.0%
52W High
$84.55
52W Low
$32.66
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$88.04M
Gross Profit
$77.91M
Operating Income
-$612.26M
Net Income
-$784.96M
Free Cash Flow
-$534.82M
Total Debt
$1.18B
Cash & Equivalents
$882.22M
Shareholder Equity
-$659.63M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $-1.67 | $-1.65 | -1.2% |
| Q4 2025 | February 24, 2026 | $-1.50 | $-1.56 | +3.9% |
| Q3 2025 | November 5, 2025 | $-1.54 | $-1.57 | +1.9% |
| Q2 2025 | August 7, 2025 | $-1.12 | $-1.36 | +17.6% |
| Q1 2025 | May 6, 2025 | $-1.36 | $-1.36 | +0.0% |
| Q4 2024 | February 27, 2025 | $-1.26 | $-1.17 | -7.3% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Cytokinetics Inc's market cap?
As of June 29, 2026, Cytokinetics Inc (CYTK) has a market capitalization of $11.16B.
Does Cytokinetics Inc pay a dividend?
Cytokinetics Inc does not currently pay a dividend.
What sector is CYTK in?
Cytokinetics Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Cytokinetics Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Cytokinetics Inc reported revenue of $88.04M and net income of -$784.96M.
Ask your own questions about CYTK
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.